The recall was initially initiated voluntarily by the manufacturer on September 10, citing deviations from Current Good Manufacturing Practice (CGMP). CGMP regulations are the framework that ensures the quality of drug products by carefully monitoring manufacturers’ compliance with federal standards. Because anticavity toothpaste is regulated by the FDA similarly to other over-the-counter (OTC) drugs, adherence to these practices is a critical safeguard for public health. The FDA’s subsequent designation of the recall as Class II on October 19 indicates a specific level of risk. A Class II recall means that exposure to or use of the product may cause temporary or medically reversible adverse health consequences, or that serious adverse health issues are unlikely.
The scope of the recall is extensive, encompassing 17 distinct product varieties under three primary brand names: Brush Buddies, Evo, and ARU. The affected products include several popular children’s items featuring licensed characters, such as Brush Buddies Barbie Anticavity Toothpaste (Bubble Gum), Brush Buddies Hot Wheels Anticavity Toothpaste (Strawberry), and Brush Buddies Crayola Silly Scents Anticavity Toothpaste in Bubble Gum, Watermelon, and Strawberry flavors. The My Little Pony variation in Bubble Gum flavor is also part of the recall. Beyond the character-branded kids’ options, the list includes a variety of flavored anticavity toothpastes, such as Vanilla Ice Cream, Mint Chocolate Chip, Cookies ’n Cream, and Chocolate Ice Cream, all in the 3.5-ounce size. Adult formulations are also affected, including Evo Advanced Whitening (Peppermint) and Evo Sensitive (Sweet Mint), as well as ARU Gum Health (Soothing Mint) and ARU Cavity Protection (Cool Mint) toothpastes.
Despite the significant volume of products involved, the FDA has not reported any injuries or illnesses associated with the recalled toothpaste. The enforcement report did not provide specific details regarding the nature of the CGMP deviations that triggered the recall. However, the agency’s guidance is clear: because the products are subject to a recall, it is safest for consumers to stop using them immediately. For those who have already used the toothpaste and have any health concerns, the FDA advises contacting a doctor right away. While no specific disposal instructions were issued, the standard recommendation is to throw the products away or return them to the point of purchase for a refund.
Consumers are encouraged to check their bathroom shelves for these specific items. To verify whether a specific tube is affected, the FDA’s enforcement report provides detailed information, including lot numbers, expiration dates, and UPCs (Universal Product Codes) for each of the 17 products. This granularity allows consumers to distinguish between recalled batches and other toothpaste products that may have been manufactured by the same company but are not subject to the recall. The inclusion of both children’s and adult products highlights the broad reach of the manufacturing deviation, affecting families across the country who rely on these brands for daily oral hygiene.
The response to this recall underscores the FDA’s role in monitoring the quality of OTC drug products. By designating the recall as Class II, the agency signals that while the risk of serious harm is low, the potential for temporary or reversible health issues warrants immediate action. For health systems and clinicians, this event serves as a reminder of the importance of supply chain transparency and manufacturing oversight in consumer health products. In the absence of reported adverse events, the primary public health goal is to prevent potential exposure by removing the affected products from circulation.
As the recall progresses, the next verified development will likely involve the completion of the return process and the removal of the remaining stock from retail shelves. Consumers should continue to monitor the FDA’s website for any updates regarding the recall status or new information about the specific manufacturing deviations. For now, the immediate step for households is to identify any Brush Buddies, Evo, or ARU toothpaste matching the recalled descriptions and discontinue their use, ensuring that the safety of the daily dental routine is maintained through the use of unaffected products.
